Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
Journal
Frontiers in Immunology
ISSN
1664-3224
Date Issued
2020
Author(s)
Gwen E. Thompson
Lynn A. Fussner
Amber M. Hummel
Darrell R. Schroeder
Francisco Silva
Melissa R. Snyder
Carol A. Langford
Peter A. Merkel
Paul A. Monach
Philip Seo
Robert F. Spiera
E. William St. Clair
John H. Stone
Ulrich Specks
Type
Resource Types::text::journal::journal article
URL Institutional Repository
Subjects
anca-associated vasculitis
;
biomarker
;
pr3-anca
;
relapse activity
;
remission
;
anti-neutrophil cytoplasmic antibody-associated vasculitis
;
antibodies, antineutrophil cytoplasmic
;
biomarkers
;
cyclophosphamide
;
humans
;
immunoassay
;
immunosuppressive agents
;
myeloblastin
;
rituximab
;
serologic tests
;
azathioprine
;
cyclophosphamide
;
myeloblastin
;
neutrophil cytoplasmic antibody
;
rituximab
;
biological marker
;
cyclophosphamide
;
immunosuppressive agent
;
myeloblastin
;
neutrophil cytoplasmic antibody
;
rituximab
;
anca associated vasculitis
;
article
;
controlled study
;
disease activity
;
double blind procedure
;
enzyme linked immunosorbent assay
;
follow up
;
human
;
immunoassay
;
major clinical study
;
multicenter study
;
phenotype
;
prospective study
;
randomized controlled trial
;
recurrence risk
;
remission
;
sensitivity and specificity
;
anca associated vasculitis
;
blood
;
clinical trial
;
immunology
;
procedures
;
serology